Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Sierra Oncology, Inc. (SRRA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/06/2022 |
SC 13D/A
| Longitude Capital Partners III, LLC reports a 5.7% stake in SIERRA ONCOLOGY, INC. |
| 03/21/2022 |
SC 13D/A
| Abingworth LLP reports a 8.9% stake in Sierra Oncology, Inc. |
| 03/15/2022 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 12.2% stake in Sierra Oncology, Inc. |
| 02/10/2022 |
SC 13D/A
| Abingworth LLP reports a 11.3% stake in Sierra Oncology, Inc. |
| 02/04/2022 |
SC 13D/A
| Longitude Capital Partners III, LLC reports a 17.4% stake in SIERRA ONCOLOGY, INC. |
| 02/02/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/08/2021 |
SC 13D/A
| Longitude Capital Partners III, LLC reports a 20.3% stake in SIERRA ONCOLOGY, INC. |
| 11/05/2021 |
SC 13D/A
| Abingworth LLP reports a 12.6% stake in Sierra Oncology, Inc. |
| 11/05/2021 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 18.1% stake in Sierra Oncology, Inc. |
| 04/29/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 2% stake in Sierra Oncology, Inc. |
| 02/10/2020 |
SC 13D/A
| Longitude Capital Partners III, LLC reports a 14.2% stake in SIERRA ONCOLOGY, INC. |
|
|